Assignee
TRELLIS BIOSCIENCE LLC
US·15 granted patents·4 pending applications·48 citations·filing 2010–2022
Top patents by PatentIndex Score
19 records- 0196US11248040B2Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2020·Granted Feb 15, 2022·7 cites·11 claims
- 0295US10570193B2Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2018·Granted Feb 25, 2020·12 cites·6 claims
- 0395US10233234B2Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2016·Granted Mar 19, 2019·18 cites·6 claims
- 0490US8362215B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2010·Granted Jan 29, 2013·9 cites·23 claims
- 0575US12152068B2Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2022·Granted Nov 26, 2024·0 cites·18 claims
- 0674US8828388B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2013·Granted Sep 9, 2014·1 cites·12 claims
- 0768US12246063B2Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereofTRELLIS BIOSCIENCE LLC·Filed 2021·Granted Mar 11, 2025·0 cites·17 claims
- 0868US11773143B2Conformational epitopes in respiratory syncytial virus G protein central conserved regionTRELLIS BIOSCIENCE LLC·Filed 2018·Granted Oct 3, 2023·1 cites·9 claims
- 0966US11725055B2Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signalingTRELLIS BIOSCIENCE LLC·Filed 2020·Granted Aug 15, 2023·0 cites·4 claims
- 1065US9321839B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2014·Granted Apr 26, 2016·0 cites·6 claims
- 1161US2021277116A1Native human antibodies for immune checkpoint modulation targets tim-3 and b7-h3TRELLIS BIOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 1258US10858431B2Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signalingTRELLIS BIOSCIENCE LLC·Filed 2017·Granted Dec 8, 2020·0 cites·7 claims
- 1355US10030069B2High affinity human antibodies to human cytomegalovirus (CMV) gB proteinTRELLIS BIOSCIENCE LLC·Filed 2017·Granted Jul 24, 2018·0 cites·12 claims
- 1453US11046764B2Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H3TRELLIS BIOSCIENCE LLC·Filed 2018·Granted Jun 29, 2021·0 cites·8 claims
- 1549US9688744B2High affinity human antibodies to human cytomegalovirus (CMV) GB proteinTRELLIS BIOSCIENCE LLC·Filed 2015·Granted Jun 27, 2017·0 cites·17 claims
- 1648US2015086561A1Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2014·Application pending·0 cites
- 1742US10654915B2Antibodies useful in passive influenza immunizationTRELLIS BIOSCIENCE LLC·Filed 2012·Granted May 19, 2020·0 cites·15 claims
- 1836US2015299298A1Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2015·Application pending·0 cites
- 1936US2015197558A1Binding moieties for biofilm remediationTRELLIS BIOSCIENCE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRELLIS BIOSCIENCE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →